Literature DB >> 25149829

Hypolipidemic effect of fenugreek seeds and its comparison with atorvastatin on experimentally induced hyperlipidemia.

Megh Shyam Sharma1, Prema Ram Choudhary2.   

Abstract

OBJECTIVE: To determine the hypolipidemic effect of fenugreek (Methi) seeds and its comparison with atorvastatin on experimentally induced hyperlipidemia in rabbits. STUDY
DESIGN: Experimental interventional study. PLACE AND DURATION OF STUDY: Department of Physiology, Dr. S. N. Medical College, Jodhpur, Rajasthan, India, from April 2012 to March 2013.
METHODOLOGY: Twenty, 1 - 2 years old albino rabbits of European Strains were randomly divided into two groups of 10 rabbits each. All were fed pure cholesterol (0.5 g/kg body weight/day) for 4 weeks to induce hyperlipidemia. Group-I comprised of 10 hyperlipidemic rabbits which were fed normal (regular) diet supplemented with 2 ml aqueous emulsified fenugreek seeds powder (500 mg/kg body weight/day) for 4 weeks. Group-II comprised of 10 hyperlipidemic rabbits, which were fed normal (regular) diet supplemented with 2 ml aqueous emulsion of atorvastatin (0.5 mg/kg body weight/day) for 4 weeks. Fasting blood samples were collected two times during experimental period at weeks (4 and 8) and analyzed for serum total cholesterol and triglycerides, using semi-automated chemistry analyzer. HDL-C was determined by precipitation method and LDL-C and VLDL-C were estimated by Friedewalds formula. LDL/HDL ratio and TG/HDL ratios were also calculated. The significance of difference in mean values of both groups (lipid profile) was assessed by independent student's t-test.
RESULTS: Atorvastatin showed a more potent hypolipidemic activity. It reduced serum total cholesterol, TG, LDL and VLDLcholesterol, and the atherogenic index (LDL-C/HDL-C; p < 0.001) highly significantly as compared to fenugreek. There was a significant increase of HDL-C (p < 0.01) in group-I as compared to group-II.
CONCLUSION: Fenugreek and atorvastatin both have hypolipidemic activity in rabbits but atorvastatin is more potent than fenugreek seeds powder.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25149829     DOI: 08.2014/JCPSP.539542

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  5 in total

1.  The Effects of Hydro-Alcoholic Extract of Fenugreek Seeds on the Lipid Profile and Oxidative Stress in Fructose-Fed Rats.

Authors:  Maryam Mohammad-Sadeghipour; Mehdi Afsharinasab; Maryam Mohamadi; Mehdi Mahmoodi; Soudeh Khanamani Falahati-Pour; Mohammad Reza Hajizadeh
Journal:  J Obes Metab Syndr       Date:  2020-09-30

2.  Efficacy and Safety of a Mixed Extract of Trigonella foenum-graecum Seed and Lespedeza cuneata in the Treatment of Testosterone Deficiency Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Hyun Jun Park; Kyeong Soo Lee; Eun Kyoung Lee; Nam Cheol Park
Journal:  World J Mens Health       Date:  2018-03-22       Impact factor: 5.400

3.  In vivo and In vitro effects of ethanolic extract of Trigonella foenum-graecum L. seeds on proliferation, angiogenesis and tube formation of endothelial cells.

Authors:  Mozhdeh Iranmanesh; Reza Mohebbati; Fatemeh Forouzanfar; Mostafa Karimi Roshan; Ahmad Ghorbani; Mohammad Jalili Nik; Mohammad Soukhtanloo
Journal:  Res Pharm Sci       Date:  2018-08

4.  Comparative lipid and uric acid suppressing properties of four common herbs in high fat-induced obese mice with their total phenolic and flavonoid index.

Authors:  Tanoy Mazumder; Imran Parvez Mamun; Md Safayat Zaman; A K M Khairul Islam; Shahjala Chowdhury; Md Sharif Reza; Md Saddam Hussain
Journal:  Biochem Biophys Rep       Date:  2021-03-30

5.  Engineering a short-chain dehydrogenase/reductase for the stereoselective production of (2S,3R,4S)-4-hydroxyisoleucine with three asymmetric centers.

Authors:  Xuan Shi; Takuya Miyakawa; Akira Nakamura; Feng Hou; Makoto Hibi; Jun Ogawa; Yeondae Kwon; Masaru Tanokura
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.